“In theory, it should already be happening,” she says. “Because the promise is there. The setup and infrastructure are there. The research is there. The biggest hurdle is reducing variability in drug production.”
These are the current aims of molecular pharming, the field that uses plants, rather than costly animal cells and materials, to produce our pharmaceuticals.
Click here to see more...